Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis

INTRODUCTION: Patients at high bleeding risk (HBR patients) represent an important subset of patients undergoing percutaneous coronary intervention (PCI). It remains unclear whether a shortened duration of dual antiplatelet therapy (DAPT) confers benefits compared with prolonged duration of DAPT in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mankerious, Nader, Megaly, Michael, Hemetsberger, Rayyan, Allali, Abdelhakim, Samy, Mohamed, Toelg, Ralph, Garcia, Santiago, Richardt, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423172/
https://www.ncbi.nlm.nih.gov/pubmed/37261649
http://dx.doi.org/10.1007/s40119-023-00318-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423172/
https://www.ncbi.nlm.nih.gov/pubmed/37261649
http://dx.doi.org/10.1007/s40119-023-00318-5

Ejemplares similares